Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05545826 · ClinicalTrials.gov registry record · NA
Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05545826: Clinical Trial NA study, sponsored by Stanford University.
NCT05545826 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05545826, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.
Interventions
- DEVICE Vibrotactile coordinated reset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05545826
The ClinicalTrials.gov registry entry for NCT05545826 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vibrotactile coordinated reset is the first listed.
NCT05545826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05545826 about?
NCT05545826 is a clinical study titled "Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease". The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used ...
What is the current status of trial NCT05545826?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-01. Estimated completion is 2027-10-20.
What interventions are being tested in trial NCT05545826?
The interventions under investigation include: Vibrotactile coordinated reset (DEVICE).
Who is sponsoring clinical trial NCT05545826?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.